Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2014
07/15/2014US8779109 Growth hormones with prolonged in-vivo efficacy
07/15/2014US8779098 B7-H3L cell surface antigen and antibodies that bind thereto
07/15/2014US8779097 Accelerated gelation of regenerated fibroin
07/15/2014US8779093 Neuronal viability factor and use thereof
07/15/2014US8779091 Methods for selective targeting
07/15/2014US8779090 Methods and compositions for the treatment of heart failure and other disorders
07/15/2014US8779089 Methods and compositions for soft tissue repair
07/15/2014US8779088 Vaccine for the treatment of Mycobacterium related disorders
07/15/2014US8778961 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
07/15/2014US8778914 Bisphosphonate-prodrugs
07/15/2014US8778905 USP47 inhibitors and methods to induce apoptosis
07/15/2014US8778902 RNA interference mediating small RNA molecules
07/15/2014US8778899 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
07/15/2014US8778891 Dermatopontin-activating peptides and cosmetic compositions including same
07/15/2014US8778890 Leptin antagonist and methods of use
07/15/2014US8778889 Antimicrobial decapeptide oral hygiene treatment
07/15/2014US8778888 Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use
07/15/2014US8778887 Therapeutic uses of soluble alpha-Klotho
07/15/2014US8778886 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
07/15/2014US8778884 Glioprotectant peptide for use in the treatment of amyotrophic lateral sclerosis (ALS) and methods related thereto
07/15/2014US8778883 Foamy biomaterial for biological tissue repair
07/15/2014US8778882 Agent for strengthening calcium containing tissue and use thereof
07/15/2014US8778881 Peptidic vasopressin receptor agonists
07/15/2014US8778880 Human growth hormone modified at position 35
07/15/2014US8778879 Homogeneous vaccine composition comprising a conjugate of EGF and P64K for the treatment of tumors
07/15/2014US8778878 Use of ferritin to treat iron disorders
07/15/2014US8778877 HCV protease inhibitors and uses thereof
07/15/2014US8778876 Small-molecule inhibitors of Dengue and West Nile virus proteases
07/15/2014US8778875 Use of an active biological substance in abnormal cellular and viral membrane physiologies
07/15/2014US8778874 Glycopeptide antibiotic monomer derivatives
07/15/2014US8778872 Amide based glucagon superfamily peptide prodrugs
07/15/2014US8778871 Metastin derivatives and use thereof
07/15/2014US8778870 Modified factor IX polypeptides and uses thereof
07/15/2014US8778869 Tissue regeneration system
07/15/2014US8778648 Enzymes for reduced immunological stress
07/15/2014US8778404 Nutritional compositions
07/15/2014US8778403 Diketopiperazine microparticles with defined specific surface areas
07/15/2014US8778389 Medicament for the treatment of fungal infections particularly aspergillosis
07/15/2014US8778376 Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
07/15/2014US8778364 Nanodispersion of a drug and process for its preparation
07/15/2014US8778354 Compositions and methods for modulating RSV infection and immunity
07/15/2014US8778350 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
07/15/2014US8778349 Modification of intrinsically disordered sequences for the preparation of vaccines
07/15/2014US8778344 Method of treating atopic dermatitis with antibody to zcytor17 ligand
07/15/2014US8778338 Combination enzyme therapy for digestion of dietary gluten
07/15/2014US8778336 Stabilized proteases that have been immobilized and further crosslinked for use in skin care
07/15/2014US8778335 Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders
07/15/2014US8778334 Method of identifying whether or not an individual has Parkinson's Disease rather than another neurodegenerative disease
07/15/2014US8778310 Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer
07/15/2014US8778303 99mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
07/15/2014US8778302 Procaspase 8-mediated disease targeting
07/15/2014CA2800946C Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same
07/15/2014CA2785633C Topical acyl glutathione formulations
07/15/2014CA2782510C Polypeptides
07/15/2014CA2687602C Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
07/15/2014CA2657949C Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
07/15/2014CA2589270C Stabilized calcium phosphate complexes
07/15/2014CA2584481C Pharmaceutical compositions based on nk2 antagonists for pediatric use
07/15/2014CA2574665C Therapeutic and diagnostic agents
07/15/2014CA2520029C Slurp-1 compositions and methods of use thereof
07/15/2014CA2505583C Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
07/15/2014CA2496485C Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis
07/15/2014CA2483913C Vascularization enhanced graft constructs comprising basement membrane
07/15/2014CA2321962C G protein-coupled receptor antagonists
07/10/2014WO2014107745A1 Metal sensitive mutants of matrix metalloproteases and uses thereof
07/10/2014WO2014107744A1 Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using the same
07/10/2014WO2014107596A1 Compositions and methods for polynucleotide transfection
07/10/2014WO2014107566A1 Surface binding of nanoparticle based drug delivery to tissue
07/10/2014WO2014107394A1 Processes for the enhanced bioleaching of ores
07/10/2014WO2014107171A1 Polymeric forms of h-nox proteins
07/10/2014WO2014107042A1 Novel antibiotic peptide derived from ribosomal protein l1 of helicobacter pylori bacteria, and use thereof
07/10/2014WO2014106967A1 Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide y as active ingredient
07/10/2014WO2014106961A1 A composition for preventing or treating an rna viral infection comprising samhd1 or a nucleic acid molecule encoding the samhd1
07/10/2014WO2014106720A1 Peptide for use in the treatment of motor neuronopathies
07/10/2014WO2014106649A1 Selective nox-1 inhibitor peptides and uses thereof
07/10/2014WO2014054981A3 Method for stimulating the growth and enhancing the resistance of livestock
07/10/2014WO2014016683A3 Topical preventative medicament against burns-related systemic inflammatory response syndrome
07/10/2014WO2003087331A3 Polyvalent cation-sensing receptor in atlantic salmon
07/10/2014US20140194598 B7-related nucleic acids and polypeptides useful for immunomodulation
07/10/2014US20140194597 Modified chimeric polypeptides with improved pharmacokinetic properties
07/10/2014US20140194593 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
07/10/2014US20140194370 Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer
07/10/2014US20140194368 Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70)
07/10/2014US20140194365 Use of endostatin peptides for the treatment of fibrosis
07/10/2014US20140194364 Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof
07/10/2014US20140194363 Compression-resistant collagen-based artificial bone repair material
07/10/2014US20140194360 Use of antithrombin in extracorporeal membrane oxygenation
07/10/2014US20140194358 Prominin-1 peptide fragments and uses thereof
07/10/2014US20140194356 Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
07/10/2014US20140194353 Compositions and methods for the treatment of nervous disorders associated with diabetes
07/10/2014US20140194350 Macrocyclic proline derived hcv serine protease inhibitors
07/10/2014US20140194348 Method of inhibiting papillomavirus proliferation and treating papillomavirus infection
07/10/2014US20140194344 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity
07/10/2014US20140194340 Diagnosing, monitoring and treating inflammation
07/10/2014US20140193519 Indibulin therapy
07/10/2014US20140193506 Protection against influenza infection by granulocyte-macrophage colony stimulating factor
07/10/2014US20140193488 In Situ Antigen-Generating Cancer Vaccine
07/10/2014US20140193485 Orally administrable liposomally encapsulated reduced glutathione, with ace inhibitors for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
07/10/2014US20140193468 Methods for preparation of neo-cartilage constructs
07/10/2014US20140193466 Silk compositions and methods of using same
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 3163